Plasma metabolomic profiling in subclinical atherosclerosis: the Diabetes Heart Study

BACKGROUND: Incidence rates of cardiovascular disease (CVD) are increasing, partly driven by the diabetes epidemic. Novel prediction tools and modifiable treatment targets are needed to enhance risk assessment and management. Plasma metabolite associations with subclinical atherosclerosis were inves...

Descripción completa

Detalles Bibliográficos
Autores principales: Chevli, Parag Anilkumar, Freedman, Barry I., Hsu, Fang-Chi, Xu, Jianzhao, Rudock, Megan E., Ma, Lijun, Parks, John S., Palmer, Nicholette D., Shapiro, Michael D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8653597/
https://www.ncbi.nlm.nih.gov/pubmed/34876126
http://dx.doi.org/10.1186/s12933-021-01419-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8653597/
https://www.ncbi.nlm.nih.gov/pubmed/34876126
http://dx.doi.org/10.1186/s12933-021-01419-y

Ejemplares similares